Submit ideas and active projects for potential commercialization to improve care for critically ill or injured patients. 

Proposals must feature an established product, prototype, MVP, or technology at Technology Readiness Level (TRL) 3 or higher, meaning proof of concept has been demonstrated through analytical or experimental work. 

This opportunity is not intended for research ideas, unmet-need statements, or preliminary concepts without a validated proof of concept. 

Applicants should be prepared to describe the current stage of development, evidence supporting feasibility, and the next milestone toward commercialization or implementation. 

Selected applicants are required to register to attend the live, in-person event on March 13, 2027.